|Objective: Seeks to achieve long-term capital appreciation that will exceed the Russell 2000® Index return over a three- to five-year time horizon.|
|Benchmark: Russell 2000 Index|
|Morningstar Category: Small Cap Blend|
Past returns shown do not guarantee future results. Current performance may be lower or higher. Call 888-736-1227 for the latest month-end returns. Return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than original cost. Other share class performance may vary.Please see page 68 of the prospectus for additional unregistered product performance.
Based on an institutional strategy with a 10-year track record, the 361 U.S. Small Cap Equity Fund seeks to deliver capital appreciation by:
- Utilizing 30 years of academic research that is rooted in the science of behavioral psychology
- Believing security prices are influenced by the opinion of perceived experts and that the behavior of these experts follows a predictable pattern
- Investing in companies that are likely to be the beneficiaries of future favorable earnings announcements and earnings estimate revisions
Why Invest in the Fund
Based on 30 years of research, the Fund’s quantitative process taps into behavioral biases in an attempt to identify stocks poised for appreciation.
Seeks growth by outperforming the Russell 2000 Index over a full market cycle through exposure to small cap companies.
Provides a compelling alpha source by forecasting changes in analyst estimates and corporate earnings announcements, which we believe drive stock prices.
Market Turbulence Resulting from COVID-19. The outbreak of COVID-19 has negatively affected the worldwide economy, individual countries, individual companies and the market in general. The future impact of COVID-19 is currently unknown, and it may exacerbate other risks that apply to the Fund.
Returns include reinvestment of dividends and income.
Investments made in small and mid-capitalization companies may be more volatile and less liquid due to limited resources or product lines and more sensitive to economic factors. The Fund may also invest in exchange-traded funds (ETFs), thus shareholders will bear additional costs and the ETF may not exactly replicate the performance it seeks to track.
You should consider the Fund’s investment objectives, risks, charges and expenses carefully before investing. For a prospectus, or summary prospectus, that contains this and other information about the Funds, call 1-888-736-1227. Please read the prospectus or summary prospectus carefully before investing.
The 361 Funds are distributed by IMST Distributors, LLC.
Total Returns* Returns shown over one year are annualized. Returns include the reinvestment of dividends and income.
Calendar Year ReturnsPast returns shown do not guarantee future results. Current performance may be lower or higher. Call 888-736-1227 for the latest month-end returns. Return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than original cost.
Please see page 68 of the prospectus for additional unregistered product performance.
For the quarter, our process generated a portfolio that received 569 net positive revisions. This is 702 greater than would be expected by randomly creating a similar-sized portfolio from the same universe. The percentage of positive revisions was 46.5% for the universe; within our portfolio, 62.9% were positive. This marks the 12th quarter since inception that our process has generated a portfolio of stocks with excess positive revisions.